AKT1 and thyroid nodule: The described effect of myo-Ins and IP6 in anticancer prevention, by inhibiting PI3K and the downregulation of Akt activity [15,16] and reducing insulin resistance, proposes myo-Ins as a protective factor for the malignant transformation of thyroid nodules and metastatic spread development (Figure 3).